First Page | Document Content | |
---|---|---|
Date: 2014-10-07 09:12:32Rare diseases Fabry disease Medical terms Fabry Enzyme replacement therapy Genzyme Patient safety Health Medicine Lipid storage disorders | Microsoft PowerPoint - Fabry Registry annual report figures redrawn.pptAdd to Reading ListSource URL: www.fabry.orgDownload Document from Source WebsiteFile Size: 723,92 KBShare Document on Facebook |
Migalastat and Enzyme Replacement Therapy Have Comparable Effects on Renal Function in Fabry Disease: Phase 3 Study Results Nicholls, K1*, Bichet, DG2, Giugliani, R3, Hughes, D4, Schiffmann, R5, Wilcox, W6, Skuban, N7, RDocID: 1tiPw - View Document | |
The Journal of Rare Disorders CochraneCornerDocID: 19CDW - View Document | |
7 November 2014 Dear Committee Re: Life Saving Drugs Programme Review Fabry Support Group of Australia SubmissionDocID: W87d - View Document | |
Minimum Recommended Schedule of Assessments for MPS I Patients Initial Assessments Every 6DocID: VV2Y - View Document | |
Pancreatic enzyme replacement therapyDocID: V3Jk - View Document |